The course of myasthenia gravis and therapies affecting outcome

作者: DAVID GROB , EDWARD L. ARSURA , NORMAN G. BRUNNER , TATSUJI NAMBA

DOI: 10.1111/J.1749-6632.1987.TB51317.X

关键词:

摘要: … improved by positive pressure and volume controlled ventilation and improved intensive care, mortality fell to 14% (p less than 0.005), and a higher proportion remained unchanged (p …

参考文章(31)
A.E. Papatestas, L.I. Alpert, Kermit E. Osserman, Ruth Sue Osserman, A.E. Kark, Studies in myasthenia gravis: Effects of thymectomy The American Journal of Medicine. ,vol. 50, pp. 465- 474 ,(1971) , 10.1016/0002-9343(71)90336-6
M.B. Walker, TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE The Lancet. ,vol. 223, pp. 1200- 1201 ,(1934) , 10.1016/S0140-6736(00)94294-6
V A Lennon, J M Lindstrom, M E Seybold, Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. Journal of Experimental Medicine. ,vol. 141, pp. 1365- 1375 ,(1975) , 10.1084/JEM.141.6.1365
PHILIP DRINKER, THE USE OF A NEW APPARATUS FOR THE PROLONGED ADMINISTRATION OF ARTIFICIAL RESPIRATION Journal of the American Medical Association. ,vol. 92, pp. 1658- 1660 ,(1929) , 10.1001/JAMA.1929.02700460014005
David Grob, Norman G. Brunner, Tatsuji Namba, THE NATURAL COURSE OF MYASTHENIA GRAVIS AND EFFECT OF THERAPEUTIC MEASURES Annals of the New York Academy of Sciences. ,vol. 377, pp. 652- 669 ,(1981) , 10.1111/J.1749-6632.1981.TB33764.X
Edward L. Arsura, High-Dose Intravenous Immunoglobulin in the Management of Myasthenia Gravis Archives of Internal Medicine. ,vol. 146, pp. 1365- 1368 ,(1986) , 10.1001/ARCHINTE.1986.00360190143020
JOHN A. SIMPSON, AN EVALUATION OF THYMECTOMY IN MYASTHENIA GRAVIS Brain. ,vol. 81, pp. 112- 144 ,(1958) , 10.1093/BRAIN/81.1.112
David Grob, A.McGehee Harvey, Abnormalities in neuromuscular transmission, with special reference to myasthenia gravis The American Journal of Medicine. ,vol. 15, pp. 695- 709 ,(1953) , 10.1016/0002-9343(53)90158-2